Your browser doesn't support javascript.
loading
Bridging thrombolysis before endovascular therapy is associated with better outcomes in patients with large infarction core.
Guo, Yu; Xu, Yong-Gang; Liu, Chao; Zhang, Heng-Zhu; Luo, Wenmiao.
Afiliação
  • Guo Y; Department of Neurosurgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.
  • Xu YG; Department of Neurosurgery, Xiamen Susong Hospital, Xiamen, China.
  • Liu C; Department of Neurosurgery, Xiamen Susong Hospital, Xiamen, China.
  • Zhang HZ; Department of Neurosurgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China wenmiaoluo@outlook.com zhanghengzhu@sina.com.
  • Luo W; Department of Neurosurgery, Xiamen Susong Hospital, Xiamen, China wenmiaoluo@outlook.com zhanghengzhu@sina.com.
J Neurointerv Surg ; 2024 Aug 08.
Article em En | MEDLINE | ID: mdl-39122255
ABSTRACT

BACKGROUND:

This study investigates the efficacy and safety of bridging intravenous thrombolysis (IVT) before endovascular therapy (EVT) compared with EVT alone in patients with large infarction core.

METHODS:

We conducted a comprehensive search of PubMed, EMBASE, and the Cochrane Library from January 2015 to June 2024. Included studies involved patients with acute ischemic stroke with an Alberta Stroke Program Early CT Score of ≤5 or an ischemic core volume of ≥50 mL. Studies were required to provide either 90-day modified Rankin Scale (mRS) score, reperfusion, symptomatic intracranial hemorrhage (sICH), or 90-day mortality.

RESULTS:

Nine observational studies with 2641 patients were analyzed. The IVT+EVT group had a higher rate of 90-day functional independence (mRS 0-2; OR 1.56, 95% CI 1.31 to 1.87; adjusted OR (aOR) 1.43, 95% CI 1.21 to 1.68) and 90-day functional outcome (mRS 0-3; OR 1.34, 95% CI 1.11 to 1.62; aOR 1.18, 95% CI 1.02 to 1.37) compared with EVT alone. There was no significant difference in successful reperfusion (OR 1.01, 95% CI 0.62 to 1.64; aOR 1.07, 95% CI 0.74 to 1.54) and 90-day mortality (OR 0.86, 95% CI 0.73 to 1.02; aOR 0.89, 95% CI 0.77 to 1.04) between the two groups. Moreover, patients who received IVT+EVT had a higher rate of sICH (OR 1.30, 95% CI 1.03 to 1.64; aOR 2.21, 95% CI 1.22 to 4.01).

CONCLUSIONS:

In patients with large infarction core, bridging IVT before EVT is associated with favorable functional outcomes compared with EVT, even though bridging therapy entails a higher risk of sICH. Further trials are needed to confirm these findings.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurointerv Surg Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurointerv Surg Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China